D
etection of Y chromosome DNA in women's vaginal tract is associated with recent sexual activity and condom use with a male partner. [1] [2] [3] [4] [5] [6] Y chromosome DNA present in male epithelial cells shed during sexual intercourse and in Y chromosome carrying sperm cells. It may be detected in 87% to 100% of women the day after unprotected vaginal intercourse and may be detected in some cases up to 15 days after. 3, 4, 6, 7 Y chromosome DNA is rarely detected in women who have abstained from intercourse for more than 2 weeks or who consistently use condoms. 1, 3, 6 Y chromosome DNA may be a particularly useful biomarker in studies of human papillomavirus (HPV) infection and sexual transmission. 7 Though most HPV transmission is thought to occur through desquamation of infected epithelial cells, 8 HPV is also known to infect sperm cells. 9 Biomarkers may be an interesting option where collecting self-reported data is impractical. Sexual behavior is difficult to capture and is subject to desirability bias, nonresponse, and faulty recall in self-reports. 10, 11 Many studies lack detailed sexual behavior data, either because they were not included in the questionnaire or due to the secondary analysis of specimens collected for other purposes, such as pap tests (eg, 12, 13 ). Some previous HPV infection studies have used infection with other sexually transmitted infections (STI) as biomarkers to help control for sexual risk (eg, 14, 15 ), but these have their limitations as most sexual encounters will not lead to STI acquisition. Prostate-specific antigen, another biomarker of semen exposure, has low usefulness for HPV/STI research due to its rapid decay. 2, 6 Y chromosome DNA has been studied as a biomarker of sexual exposures mostly under highly controlled conditions, where small samples of highly motivated women agreed to self-regulate their sexual activity according to an experimental protocol, or where women are experimentally inseminated. [1] [2] [3] [4] 6, 16 However, data to assess its association with sexual behaviors in observational settings are still lacking, 17 and it is still unclear to what extent experimental data are generalizable to observational populations. In this study, our objective was to ascertain whether Y chromosome DNA positivity and quantity are associated with self-reported sexual behavior and identify which behaviors are independent predictors of Y chromosome DNA positivity and quantity in an observational setting.
MATERIALS AND METHODS

Study Design
We analyzed secondary data from participants recruited to the HPV Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) cohort study. [18] [19] [20] [21] The study was designed to study HPV transmission among newly formed young heterosexual couples. The study enrolled young women attending a university or college in Montréal, Canada, and their male partners throughout 2005 to 2010. Eligible couples were in a sexual partnership in 6 months or less; women were eligible if they were aged 18 to 24 years and men if they were 18 years or older. The study was approved by the ethical institutional review boards of McGill and Concordia Universities. Participants provided written informed consent for study participation and for the storage and use of their specimens in future studies.
We analyzed cross-sectional data from participants' baseline clinic visit and questionnaires. Women were asked to schedule visits at a time they were not menstruating. Women self-collected a vaginal specimen at baseline with a Dacron swab (Invista, Inc, Wichita, KS) at the clinic after receiving instructions by the research nurse. Both men and women independently completed self-administered online questionnaires on their sexual behaviors with their HITCH partner and with any concurrent/previous partners (see Supplemental Digital Content 1, http://links.lww.com/ OLQ/A184 for questionnaire). Participants were asked to recall the last dates of vaginal sex with current and previous partners. Participants had been instructed to abstain from intercourse in the 24 hours preceding the specimen collection, but could indicate in the questionnaire if this was not the case. Participants were asked to report on a categorical scale the proportion of all vaginal sex acts with their partner where they had used condoms; the proportion of sexual encounters with their HITCH partner where they received oral/digital sex; and whether a condom had ever slipped, broken, been removed early or applied late during their partnership.
Y Chromosome DNA Detection and Quantification
We used MasterPure (Epicentre, Madison, Wis) to isolate the DNA from vaginal samples. Cells were lysed and DNA was precipitated in isopropanol. After centrifugation at 14,000 rpm for 30 minutes at room temperature, the supernatant was discarded, and the cell pellet was left to dry and resuspended in 150 μL of 20 mmol/L Tris buffer (pH, 8.3). We used a real-time polymerase chain reaction (PCR) assay to detect samples with inhibitors. 22 The samples with inhibition were diluted by one quarter and retested for the presence of inhibition. Samples and diluted samples without inhibition were then tested using 2 PCR assays. The first assay used a validated protocol to detect and amplify the SRY gene sequence, which is specific to Y chromosomes. 23 The second assay quantified the total number of cells in the sample using the amplification of a β-globin gene segment found in both male and female cells. Samples were evaluated in duplicate with the Light Cycler PCR and detection system (Roche Molecular Systems, Laval, Québec) to quantify the number of copies of SRY and β-globin genes. For the SRY assay, 2 μL of treated specimen were amplified in a 20-μL reaction mix with 3 mM of MgCl 2 , 0.3 pmol of primers for SRY-109 (5′-TGGCGATTAAGTCAAATTCGC-3′) and SRY 245 (5′-CCCCCTAGTACCCTGACAATGTATT-3′), and 0.3 pmol of probe for SRY (5′-AGCAGTAGAGCAGTCAGGGAGGCAGA-3′) with FastStart enzyme. We quantified Y chromosome DNA by comparing the cycle where exponential amplification started for each specimen to a standard curve produced by serial dilutions of DNA from quantified cells of prostatic origin available in our laboratory. We determined the level of analytical sensitivity of the assay using a titration curve produced by serial dilutions of DNA and found a detection limit of 1 copy of SRY per test (2 μL of extracted DNA). We performed the β-globin PCR assay as previously described 24 and determined the total quantity of cells using serial dilutions of human genomic DNA (Roche Diagnostics, Indianapolis, Ind) in 10 mM Tris-HCl (pH, 8.2). Sample processing and testing was done by female research assistants only to prevent contamination. All negative controls were negative in PCR assays.
Statistical Analysis
Analyses were restricted to partnerships where the woman's sample had valid β-globin DNA test results and which had nonmissing data for questionnaire items. Y chromosome DNA in vaginal samples was analyzed as a binary outcome (positive/ negative) and a quantitative outcome (the proportion of cells with Y chromosome DNA [male cells] in the vaginal sample). The proportion of male cells was calculated by dividing the number of copies of SRY DNA (1 copy/cell) by the total number of exfoliated cells in the vaginal sample with β-globin DNA (2 copies/cell). We used logistic regression and the exact Cochrane-Armitage test to identify the predictors of Y chromosome DNA positivity and used negative binomial regression to model the proportion of male cells (using the number cells with Y chromosome DNA as the outcome and the log-transformed total number of exfoliated cells from vaginal samples as the offset). We evaluated as univariate model predictors the sexual behavior questionnaire items we hypothesized might be associated with male cell deposition in the vagina (frequency and time since vaginal sex, condom use, oral/digital sex frequency, whether the woman had concurrent partners). We included in multivariable models only those variables which were significantly associated with Y chromosome DNA outcomes in univariate analyses using a cutoff of P less than 0.05. We considered that the number of days since a woman's last vaginal sex was the most recent between either (1) the date she reported last having vaginal sex with her HITCH partner or any other partner, or (2) the date her male HITCH partner reported last having vaginal sex with her. We used the woman's reports for all other sexual behaviors. In sensitivity analyses, we evaluated the influence of condom user error by recoding "always" users as "most times" users if either partner reported any condom breakage, slippage, delayed application, or early removal.
We performed subgroup analyses to explore potential modifying effects of condom use and time since last vaginal sex. We used the Cochrane-Armitage trend test to identify the behaviors which might potentially explain Y chromosome DNA positivity in each subgroup.
RESULTS
All Women
At the baseline visit, 494 of the 502 enrolled women had samples with valid β-globin DNA results. Women and their male partners were on average aged 21.1 and 22.7 years, and 62.3% of partnerships reported vaginal sex in the past 2 days (Table 1) . 
Subgroup Analyses
Condom use modified the association between days since last sex and Y chromosome DNA positivity and quantity. Women in partnerships who reported having sex in the last 0 to 1 day and who reported never using condoms had a 94% probability of being positive for Y chromosome DNA, compared with 28% for those who reported always using condoms (Table 3) . Women who reported always using condoms had a very low mean proportion of male cells regardless of days since last vaginal sex (0.00-0.01%) compared with women who reported not always using condoms who had very high mean proportions of male cells if they last had vaginal sex in the last 0 to 1 day (2.41-4.89%) and 2 days (0.10-1.73%) (Fig. 1) . For women who reported always using condoms, positivity tended to increase with the reported average frequency of vaginal sex acts (P = 0.0042) but not with the frequency of digital and oral sex they received from their partner (P = 0.26-0.47) (not shown).
In the 45 women in partnerships whose last reported vaginal sex was more than 7 days ago, Y chromosome DNA positivity was highest in those who reported more frequently receiving oral and digital sex from their partner (P = 0.02-0.03) (see Table, Supplemental Digital Content 2, http://links.lww.com/OLQ/A185 women in partnerships whose last reported vaginal sex was >7 days ago). Condom use was not associated with Y chromosome DNA positivity in these women (P = 0.76). There were 2 women who reported always using condoms and in partnerships reporting vaginal sex more than 7 days ago who were Y chromosome DNA positive. Both only had a low proportion of cells with Y chromosome DNA (0.02% and 0.06%). Neither of these women nor their partners reported any condom user error.
DISCUSSION
In this cross-sectional study of young adult heterosexual couples, we found that the self-reported number of days since last vaginal sex and condom use were strongly and independently associated with both Y chromosome DNA positivity and quantity in women's vaginal samples. Particularly, the quantity of Y chromosome DNA in vaginal samples dramatically decreased with the reported days since last vaginal sex and with increased condom use. Although Y chromosome DNA was detected in 22% of women who self-reported always using condoms, the quantity of male cells with Y chromosome DNA in their samples was approximately 50-fold lower compared with women who self-reported never using condoms.
Our results are similar to controlled experimental studies in monogamous women recruited in clinics or universities, [1] [2] [3] [4] 6, 7 which supports generalizing results from experimental studies to an observational setting. Y chromosome DNA positivity and quantity generally decline sharply the first 3 days after vaginal sex or artificial insemination. 2, 4, 6, 7, 25 Our results were comparable to Brotman et al 4 who found that 87% of women were Y chromosome DNA-positive the day after unprotected intercourse, 36% to 49% positive after 3 days, and 13% to 18% positive after a week of abstinence. Up to 18% of women have also been found to be still Y chromosome DNA-positive 15 days after intercourse in another study. 6 The overall consistency of results between observational and experimental studies suggests that results are widely generalizable to other populations of women.
We found a stronger association between sexual behavior and the quantity of Y chromosome DNA than when Y chromosome DNA was considered as a binary outcome (positive/ negative). Although studies interested in exposure to any unprotected sex may find a binary measure more useful, our data support using a quantitative measure of Y chromosome DNA as a stronger correlate of time since last sex and condom use. Previous studies which detected Y chromosome DNA in women who reported consistently using condoms concluded that selfreported condom use was inaccurate or that high condom user error prevails. 26, 27 However, their population was younger than ours and was interviewed using a different method and so may not be entirely comparable. In our sample, the positive women who self-reported always using condoms had approximately 50-fold lower quantities of Y chromosome DNA compared with the positive women who self-report never using condoms. Experimental studies have similarly found low levels of Y chromosome DNA detection even with consistent condom use. 7, 25 We did not find that correcting for self-reported ever condom breakage, slippage, or partial use accounted for Y chromosome DNA positivity. Although these women could have misreported their condom use or incorrectly used condoms, it is also possible that condoms may not completely prevent deposition of male epithelial cells which are another source of Y chromosome DNA. Our PCR assay was designed to capture Y chromosome DNA from both epithelial or sperm cells, as both can be biomarkers of sexual exposure. Though in our study all quality controls were negative and there was no evidence of false positives due to contamination, we also cannot exclude this possibility.
We generally did not find that the frequency of oral and digital sex women received was associated with Y chromosome DNA positivity and quantity, except in the subgroup of women who last had vaginal sex more than 7 days ago. Due to the low number of observations, these results should be cautiously interpreted. Ghanem et al 1 found that receptive oral and digital sex within 48 hours of sampling could lead to Y chromosome DNA detection, albeit at much lower quantities than with vaginal sex. It is possible that any deposition from oral and digital sex in our study was masked by the much stronger associations with vaginal sex and condom use.
Like most behavioral studies, we relied on individuals' selfreported sexual behaviors. We used various methods to improve measurement validity, ensuring patients knew their information was confidential and using secure Web-based self-administered questionnaires. The very strong association between self-reported vaginal sex, condom use, and Y chromosome DNA quantity suggests self-reported sexual behavior was a good measure of actual sexual behavior in our study. The accuracy of self-reporting will depend on the quality of data collection methods and may be lower in other studies and settings (eg, STI clinics 28 ). There is likely to be some misclassification of days since last vaginal sex, because only 51% of partners reported the same date for their last vaginal sex with each other. We used the most recent of both partners' reported dates because we found a stronger association with Y chromosome DNA than when we used only the women's reported dates (not shown). This suggests that individuals tended to overestimate the date of last sex due to poor recall over time. It is a particular strength of our study that we could use this information from both partners, compared with most studies of sexual behavior which would only have data from 1 individual. Misreporting is likely to be nondifferential according to the outcome as participants were unaware of their Y chromosome DNA results, which would lead to an underestimation of its association with sexual behavior.
Biomarkers of semen exposure have been hailed as objective markers of sexual behavior considered by many superior to self-reporting. 11, 17 Most interest in biomarkers to date has been for identifying individuals suspected of misreporting or violating protocol. However, neither biomarkers nor questionnaires have perfect measurement sensitivity or specificity for underlying complex behaviors. 1, 2, 29 The potential for small depositions from oral or digital sex and the potential for specimen contamination further complicate the interpretation of a positive Y chromosome DNA result.
Nevertheless, the very strong associations we observed suggest that at the aggregate level, Y chromosome DNA quantity in vaginal samples is very strongly correlated to recent sexual activity and could be useful in epidemiologic analyses for confounder control or as a proxy of some behaviors that could have been measured using questionnaires. We expect biomarkers, such as Y chromosome DNA, could be especially useful for surveillance of HPV infection in vaccinated and screened population. In a study of HPV infection in Australian women attending cervical cancer screening, Tabrizi et al 30 were unable to control for any differences in sexual behavior pre-and post-HPV vaccination as sexual behavior data only started being collected postvaccination; the effectiveness of number of HPV vaccine doses is being monitored in Scotland through record linkage and samples from the organized screening program with only birth cohort year and deprivation score available for confounder adjustment. 31 Both of these are examples of studies where biomarkers could provide further information where there is a lack of comparable sexual risk data between periods and cohorts. As more and more jurisdictions start to screen for cervical cancer with HPV testing, there is likely to be increasing data on HPV infection without appended sexual behavior data.
In conclusion, we found that Y chromosome DNA had a similar performance in a large-scale observational study as previously reported in smaller controlled experiments, supporting its utility as a proxy of recent vaginal sex (≤3 days) and lack of condom use in observational settings. Quantitative measures of Y chromosome DNA will be a stronger correlate of these behaviors than binary measures of Y chromosome DNA positivity. Y chromosome DNA was not strongly associated with oral/digital sex frequency and partner concurrency in an observational setting. Biomarkers, such as Y chromosome DNA, do not replace the need for quality measurements of self-reported sexual behavior. Many complex behaviors will be impossible to study using biomarkers, and self-reported sexual behaviors are generally still found to be very strong predictors of STI infection despite their inherent biases. 20, 21 Y chromosome DNA could nonetheless be useful in epidemiological studies as proxies to reduce residual confounding where sexual behavior was not measured or is suspected to be misreported.
